Projects

Preclinical Studies under GLP Compliance

• A total of 34 preclinical studies have been successfully completed in accordance with OECD-GLP standards.

• 11 preclinical studies are currently ongoing in our laboratories.

International Projects

• Horizon Europe Pathfinder Project
  NeoVasculoStop Horizon Pathfinder Project
  - Ongoing

Government-Funded R&D Projects

• TÜBİTAK 1007 Program
  Development and production of a biosimilar product containing a monoclonal antibody or antibody fragment
  ✔️ Completed

• TÜBİTAK 1004 Program
  Targeted Pan-Cancer Therapies (PAN-TER)
  - Ongoing

Product Categories Studied

In the scope of our completed and ongoing projects, we have conducted comprehensive analyses on a wide range of product groups, including:

• Vaccines (viral, recombinant, adjuvanted)
• Medicines (small molecules, generic products)
• Biotechnological Products (monoclonal antibodies, biosimilars, peptide/protein-based therapeutics)
• Chemical Substances (active ingredients, excipients, adjuvants, co-solvents)

Models and Application Areas

Our laboratories develop and apply both in vivo and in vitro models for various disease indications.

Disease Models

• Cancer Models
• Macular Degeneration Model
• Neurodegenerative Disease Models
• Inflammatory and Autoimmune Models

Experimental Application Areas

• Toxicity Studies
  (acute, subacute, repeated dose, local tolerance, etc.)

• Pharmacokinetic Evaluations
  (bioavailability, distribution, elimination)

• Pharmacodynamic Assessments
  (efficacy profiling, target engagement)